← Open Payments lookup

RICHARD DYER: Open Payments

NPI 1720676489 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$231 in 11 payments from 9 companies in 2025. Trend: 2023 $82 · 2024 $351 · 2025 $231

Food & beverage: $231
CompanyPaymentsAmount
ABBVIE INC.3$59
Gilead Sciences, Inc.1$30
Daiichi Sankyo Inc.1$29
SANOFI PASTEUR INC.1$26
Biogen, Inc.1$20
Lilly USA, LLC1$18
MEDICOMP INC1$18
Otsuka America Pharmaceutical, Inc.1$17
AstraZeneca Pharmaceuticals LP1$14

Products named: QULIPTA, INJECTAFER, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, SPINRAZA, MOUNJARO, TELEPATCH CARDIAC MONITOR, REXULTI, UBRELVY.

Industry payments across PA — which companies pay providers there.